Siham Sabri

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Venues

Cancers

Cancer research

JNCI cancer spectrum

McGill University Faculty of Medicine

Université Paris Diderot (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

McGill University Faculty of Medicine Sep 01 2017

Canada

Assistant Professor :: Department of Pathology

McGill University Health Centre Aug 01 2011

Canada

Principal Investigator :: Research Institute

McGill University Faculty of Medicine Aug 01 2011 - Aug 31 2017

Canada

Assistant Professor :: Department of Oncology

University of Alberta Apr 01 2006 - Jul 31 2011

Canada

Research Associate (Level II) :: Division of Experimental Oncology, Cross Cancer Institute, Faculty of Medicine

Institut Gustave Roussy École doctorale de cancérologie Jul 01 2000 - Feb 01 2004

France

Post-doctoral Research Fellow :: Hematopoiesis and Stem Cell Research Laboratory

University of Birmingham Jan 01 1999 - Jun 30 2000

United Kingdom

Post-doctoral Research fellow :: Biochemistry Department, School of Biosciences

Education History

Université Paris Diderot Sep 01 1995 - Aug 31 1998

France

PHD :: Faculty of Medicine Xavier Bichat

Université Paris Diderot Sep 01 1994 - Aug 31 1995

France

MSC :: Faculty of Medicine Xavier Bichat

Aix-Marseille Université Sep 01 1993 - Aug 31 1994

France

BSC :: Faculty of Biological Sciences

Publications

Elvis Martinez-Jaramillo, Fatemeh Jamali, Farah H Abdalbari, Bassam Abdulkarim, Bertrand J Jean-Claude, Carlos M Telleria, Siham Sabri
Pro-Oxidant Auranofin and Glutathione-Depleting Combination Unveils Synergistic Lethality in Glioblastoma Cells with Aberrant Epidermal Growth Factor Receptor Expression. Cancers 16 (13) (2024)
Elvis Martinez-Jaramillo, Fatemeh Jamali, Farah H Abdalbari, Bassam Abdulkarim, Bertrand J Jean-Claude, Carlos M Telleria, Siham Sabri
Pro-Oxidant Auranofin and Glutathione-Depleting Combination Unveils Synergistic Lethality in Glioblastoma Cells with Aberrant Epidermal Growth Factor Receptor Expression. Cancers 16 (13) (2024)
Farah H Abdalbari, Elvis Martinez-Jaramillo, Benjamin N Forgie, Estelle Tran, Edith Zorychta, Alicia A Goyeneche, Siham Sabri, Carlos M Telleria
Auranofin Induces Lethality Driven by Reactive Oxygen Species in High-Grade Serous Ovarian Cancer Cells. Cancers 15 (21) (2023)
David J H Bian, Siham Sabri, Bassam S Abdulkarim
Interactions between COVID-19 and Lung Cancer: Lessons Learned during the Pandemic. Cancers 14 (15) (2022)
Meiou Dai, Julien Boudreault, Ni Wang, Sophie Poulet, Girija Daliah, Gang Yan, Alaa Moamer, Sergio A Burgos, Siham Sabri, Suhad Ali, Jean-Jacques Lebrun
Differential Regulation of Cancer Progression by CDK4/6 Plays a Central Role in DNA Replication and Repair Pathways. Cancer research 81 (5) (2020)
Gloria Assaker, Anne Camirand, Bassam Abdulkarim, Atilla Omeroglu, Jean Deschenes, Kurian Joseph, Abu Shadat Mohammod Noman, Agnihotram V Ramana Kumar, Richard Kremer, Siham Sabri
PTHrP, A Biomarker for CNS Metastasis in Triple-Negative Breast Cancer and Selection for Adjuvant Chemotherapy in Node-Negative Disease. JNCI cancer spectrum 4 (1) (2019)
Ahmad Chaddad, Paul Daniel, Siham Sabri, Christian Desrosiers, Bassam Abdulkarim
Integration of Radiomic and Multi-omic Analyses Predicts Survival of Newly Diagnosed IDH1 Wild-Type Glioblastoma. Cancers 11 (8) (2019)

Siham Sabri.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Siham Sabri